Research Library

Center for Health and Biosciences

Biomedical Research

The high cost of Hepatitis C drugs

Hagop M. Kantarjian

The high cost of Hepatitis C drugs.

Nonresident fellow Hagop Kantarjian examines how the high price of Hepatitis C drugs has made treatment unaffordable, leading to the deaths of up to 500,000 people annually that could prevented. Houston Chronicle: http://bit.ly/2iYq3YX.